Joel M Montgomery
Overview
Explore the profile of Joel M Montgomery including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
198
Citations
5087
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Bergeron E, Chiang C, Lo M, Karaaslan E, Satter S, Rahman M, et al.
Emerg Microbes Infect
. 2024 Aug;
13(1):2398640.
PMID: 39194145
Nipah virus (NiV) is an emerging zoonotic RNA virus that can cause fatal respiratory and neurological diseases in animals and humans. Accurate NiV diagnostics and surveillance tools are crucial for...
12.
Karaaslan E, Sorvillo T, Scholte F, ONeal T, Welch S, Davies K, et al.
NPJ Vaccines
. 2024 Aug;
9(1):148.
PMID: 39143104
Immunizing mice with Crimean-Congo hemorrhagic fever virus (CCHFV) nucleoprotein (NP), glycoprotein precursor (GPC), or with the GP38 domain of GPC, can be protective when the proteins are delivered with viral...
13.
Whitmer S, Whitesell A, Mobley M, Talundzic E, Shedroff E, Cossaboom C, et al.
Lancet Reg Health Am
. 2024 Aug;
37:100836.
PMID: 39100240
Background: In the United States (U.S.), hantavirus pulmonary syndrome (HPS) and non-HPS hantavirus infection are nationally notifiable diseases. Criteria for identifying human cases are based on clinical symptoms (HPS or...
14.
Verani J, Eno E, Hunsperger E, Munyua P, Osoro E, Marwanga D, et al.
PLoS One
. 2024 Aug;
19(8):e0305700.
PMID: 39088453
Acute febrile illness (AFI) is a common reason for healthcare seeking and hospitalization in Sub-Saharan Africa and is often presumed to be malaria. However, a broad range of pathogens cause...
15.
Moore K, Mehr A, Ostrowsky J, Ulrich A, Moua N, Fay P, et al.
Lancet Infect Dis
. 2024 Jul;
24(11):e707-e717.
PMID: 38964362
Nipah virus causes highly lethal disease, with case-fatality rates ranging from 40% to 100% in recognised outbreaks. No treatments or licensed vaccines are currently available for the prevention and control...
16.
Michon M, Muller-Schiffmann A, Lingappa A, Yu S, Du L, Deiter F, et al.
Open Biol
. 2024 Jun;
14(6):230363.
PMID: 38889796
We present a novel small molecule antiviral chemotype that was identified by an unconventional cell-free protein synthesis and assembly-based phenotypic screen for modulation of viral capsid assembly. Activity of PAV-431,...
17.
Waltenburg M, Kainulainen M, Whitesell A, Nyakarahuka L, Baluku J, Kyondo J, et al.
Vaccine
. 2024 Jun;
42(22):126031.
PMID: 38880693
Background: The rVSVΔG-ZEBOV-GP Ebola vaccine (rVSV-ZEBOV) has been used in response to Ebola disease outbreaks caused by Ebola virus (EBOV). Understanding Ebola knowledge, attitudes, and practices (KAP) and the long-term...
18.
Aida-Ficken V, Kelly J, Chatterjee P, Jenks M, McMullan L, Albarino C, et al.
Antiviral Res
. 2024 Jun;
228:105923.
PMID: 38844175
There are no approved vaccines or therapeutics for Lassa virus (LASV) infections. To identify compounds with anti-LASV activity, we conducted a cell-based screening campaign at biosafety level 4 and tested...
19.
Komakech A, Whitmer S, Izudi J, Kizito C, Ninsiima M, Ahirirwe S, et al.
BMC Infect Dis
. 2024 May;
24(1):520.
PMID: 38783244
Background: On 20 September 2022, Uganda declared its fifth Sudan virus disease (SVD) outbreak, culminating in 142 confirmed and 22 probable cases. The reproductive rate (R) of this outbreak was...
20.
Sorvillo T, Karaaslan E, Scholte F, Welch S, Coleman-McCray J, Genzer S, et al.
NPJ Vaccines
. 2024 May;
9(1):88.
PMID: 38782933
Crimean-Congo hemorrhagic fever virus (CCHFV) can cause severe human disease and is considered a WHO priority pathogen due to the lack of efficacious vaccines and antivirals. A CCHF virus replicon...